| Literature DB >> 26106444 |
Assem Barakat1, Abdullah Mohammed Al-Majid2, Saied M Soliman3, Yahia Nasser Mabkhot2, M Ali2, Hazem A Ghabbour4, Hoong-Kun Fun5, Abdul Wadood6.
Abstract
BACKGROUND: Chalcones (1,3-diaryl-2-propen-1-ones, represent an important subgroup of the polyphenolic family, which have shown a wide spectrum of medical and industrial application. Due to their redundancy in plants and ease of preparation, this category of molecules has inspired considerable attention for potential therapeutic uses. They are also effective in vivo as anti-tumor promoting, cell proliferating inhibitors and chemo preventing agents.Entities:
Keywords: Aldol product; Chalcone; DFT compution; PAAS; X-Ray
Year: 2015 PMID: 26106444 PMCID: PMC4477317 DOI: 10.1186/s13065-015-0112-5
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Scheme 1Preparation of the title compound 3
Fig. 1The ORTEP diagram of the final X-ray model of 3 with displacement ellipsoids drawn at 30 % probability level
The crystal and experimental data of compound 3
| Crystal data | |
|---|---|
| Chemical formula | C22H20O |
|
| 300.38 |
| Crystal system, space group | Orthorhombic, |
| Temperature (K) | 100 |
|
| 27.3605 (9), 7.8271 (3), 7.4710 (2) |
|
| 1599.94 (9) |
|
| 4 |
| Radiation type | Mo Kα |
| μ (mm − 1) | 0.07 |
| Crystal size (mm) | 0.67 × 0.27 × 0.16 |
| Data collection | |
| Diffractometer | BrukerAPEX-II D8 Venture diffractometer |
| Absorption correction | Multi-scan |
| SADABS V2012/1 (Bruker AXS Inc.) | |
| Tmin, Tmax | 0.94, 0.99 |
| No. of measured, independent and observed [I > 2σ (I)] reflections | 38877, 4902, 4472 |
| Rint | 0.042 |
| Refinement | |
| R [F2 > 2σ (F2)], wR (F2), S | 0.041, 0.107, 1.05 |
| No. of reflections | 4902 |
| No. of parameters | 211 |
| No. of restraints | 1 |
| H-atom treatment | H-atom parameters constrained |
| Δρmax, Δρmin (e Å−3) | 0.39, −0.19 |
Hydrogen-bond geometry (Å, °) of 3
| D—H · · · A | D—H | H · · · A | D · · · A | D—H · · · A |
|---|---|---|---|---|
| C2—H2A · · · Cg2 | 0.9300 | 2.92 | 3.7101 (17) | 143 |
| C4—H4A · · · Cg1 | 0.9300 | 2.59 | 3.3807 (17) | 143 |
| C16—H16A · · · Cg1 | 0.9300 | 2.98 | 3.5506 (17) | 121 |
| C21—H21C · · · Cg2 | 0.9600 | 2.84 | 3.624 (2) | 140 |
| C22—H22B · · · Cg3 | 0.9600 | 2.83 | 3.754 (2) | 162 |
Symmetry code: (i) 1-X,1-Y,-1/2 + Z. (ii) 1/2-X,Y,1/2 + Z. (iii) 1/2-X,Y,-1/2 + Z
Cg1 is the centroid of the C1–C3/C8–C10 ring, Cg2 is the centroid of the C3–C8 ring and Cg3 is the centroid of the C14–C19 ring. No significant hydrogen bonds were found
Fig. 2The crystal packing of 3
The calculated and experimental geometric parameters of the studied compound 3 using B3LYP/6–311G (d,p) method
| Parameter | Calc. | Exp | Parameter | Calc. | Exp |
|---|---|---|---|---|---|
| R (1–19) | 1.223 | 1.228 | A (4–6–7) | 122.5 | 121.7 |
| R (2–4) | 1.369 | 1.366 | A (4–6–15) | 118.6 | 119.2 |
| R (2–18) | 1.422 | 1.420 | A (7–6–15) | 118.9 | 119.1 |
| R (4–6) | 1.421 | 1.425 | A (6–7–8) | 118.8 | 119.7 |
| R (6–7) | 1.418 | 1.418 | A (6–7–9) | 120.8 | 120.7 |
| R (6–15) | 1.430 | 1.423 | A (6–15–13) | 119.0 | 119.0 |
| R (7–9) | 1.375 | 1.371 | A (6–15–16) | 119.0 | 118.9 |
| R (9–11) | 1.414 | 1.413 | A (7–9–11) | 120.4 | 120.3 |
| R (11–13) | 1.374 | 1.374 | A (9–11–13) | 120.2 | 120.4 |
| R (13–15) | 1.419 | 1.421 | A (11–13–15) | 120.8 | 120.5 |
| R (15–16) | 1.418 | 1.420 | A (13–15–16) | 122.1 | 122.1 |
| R (16–18) | 1.380 | 1.378 | A (15–16–18) | 121.3 | 120.7 |
| R (18–19) | 1.502 | 1.499 | A (16–18–19) | 122.9 | 122.6 |
| R (19–20) | 1.484 | 1.477 | A (18–19–20) | 121.7 | 121.0 |
| R (20–22) | 1.345 | 1.342 | A (20–22–24) | 128.3 | 128.4 |
| R (22–24) | 1.472 | 1.469 | A (22–24–25) | 123.5 | 123.6 |
| R (24–25) | 1.416 | 1.415 | A (22–24–31) | 117.5 | 117.1 |
| R (24–31) | 1.420 | 1.416 | A (25–24–31) | 118.9 | 119.3 |
| R (25–26) | 1.398 | 1.398 | A (24–25–26) | 119.0 | 118.9 |
| R (25–32) | 1.512 | 1.510 | A (24–25–32) | 123.6 | 123.8 |
| R (26–28) | 1.392 | 1.391 | A (24–31–29) | 119.8 | 119.6 |
| R (28–29) | 1.396 | 1.392 | A (24–31–40) | 121.5 | 121.7 |
| R (28–36) | 1.508 | 1.508 | A (26–25–32) | 117.4 | 117.2 |
| R (29–31) | 1.391 | 1.393 | A (25–26–28) | 122.6 | 122.0 |
| R (31–40) | 1.512 | 1.513 | A (25–32–33) | 110.0 | 109.5 |
| A (1–19–20) | 118.8 | 119.8 | A (26–28–29) | 117.8 | 118.5 |
| A (4–2–18) | 120.7 | 120.7 | A (26–28–36) | 121.4 | 120.6 |
| A (2–4–5) | 120.2 | 119.8 | A (29–28–36) | 120.9 | 120.9 |
| A (2–4–6) | 121.0 | 120.5 | A (28–29–31) | 121.9 | 121.5 |
| A (2–18–16) | 119.3 | 120.0 | A (30–29–31) | 118.9 | 119.2 |
| A (2–18–19) | 117.6 | 117.2 | A (29–31–40) | 118.7 | 118.5 |
Fig. 3The optimized molecular structure of 3
Fig. 4Comparison between the calculated and experimental geometric parameters (bond distances and bond angles) of 3
The natural atomic charges calculated at the B3LYP/6–311G (d,p) method
| Atom | NAC | Atom | NAC |
|---|---|---|---|
| O1 | −0.5524 | H23 | 0.2043 |
| C2 | −0.1644 | C24 | −0.0997 |
| H3 | 0.2212 | C25 | 0.0298 |
| C4 | −0.1730 | C26 | −0.2169 |
| H5 | 0.2032 | H27 | 0.1961 |
| C6 | −0.0445 | C28 | 0.0140 |
| C7 | −0.1776 | C29 | −0.2200 |
| H8 | 0.2024 | C30 | 0.1960 |
| C9 | −0.1886 | C31 | 0.0310 |
| H10 | 0.2028 | C32 | −0.5901 |
| C11 | −0.1976 | H33 | 0.2026 |
| H12 | 0.2030 | H34 | 0.2084 |
| C13 | −0.1710 | H35 | 0.2171 |
| H14 | 0.2006 | C36 | −0.5829 |
| C15 | −0.0579 | H37 | 0.2024 |
| C16 | −0.1576 | H38 | 0.2055 |
| H17 | 0.2087 | H39 | 0.2096 |
| C18 | −0.1253 | C40 | −0.5897 |
| C19 | 0.5286 | H41 | 0.2047 |
| C20 | −0.2669 | H42 | 0.2083 |
| H21 | 0.2114 | H43 | 0.2063 |
| C22 | −0.1419 |
Fig. 5Molecular electrostatic potentials (MEP) mapped on the electron density surface calculated by the DFT/B3LYP
Fig. 6The ground state isodensity surface plots for the frontier molecular orbitals
Fig. 7The calculated (a) and experimental (b) electronic spectra of 3
Fig. 8The correlation graphs between calculated and experimental 1H-NMR and 13C-NMR chemical shifts of the 3
Fig. 9The experimental (lower) and calculated (upper) infrared spectra of the 3
The calculated and experimental wavenumbers of the studied compound 3
| Assignment | Calculated | Experimental |
|---|---|---|
| υ (CH, aromatic) | 3096–3046 | 3090–3030 |
| υ (=C20H21) | 3092 | 3090 |
| υ (=C22H23) | 3053 | |
| υ (CHasym, CH3) | 3011–2971 | 3016–2919 |
| υ (CHsym, CH3) | 2928–2922 | 2852 |
| υ (C=O) | 1649 | 1626 |
| υC20=C22 | 1614 | 1604 |
| υC=C (aromatic) | 1611–1489 | 1546–1500 |
| δCH in-plane methyl | 1466–1441 | 1469–1433 |
| δCH out-of-plane methyl | 1419–1396 | 1391 |
| δmethyl umbrella | 1373–1367 | 1365 |
| δCH aromatic in plane | 1362–1333, 1265–1116, 1008 | 1353, 1345, 1237–1130 |
| δ (=C-H in plane) | 1318, 1278 | 1299, 1290 |
| δCH aromatic out-of-plane | 967, 960, 937, 904–816, 765, 748–691 | 975, 960, 885–827, 760, 745–680 |
| δ (=C-H out-of-plane) | 995, 883 | 996, 885 |
| δmethyl rocking | 1049–1014 | 1070–1015 |
υ streching, δ bending
Fig. 10Correlation graph between the calculated and experimental vibrational frequencies of the studied compound
Fig. 11The TGA curve of 3
Fig. 12a The title compound 3 was fit well in the cavity of histone acetyltransferase enzyme. b Docking conformation of title compound 3 (generated by MOE docking software) properly accommodated into the binding cavity of histone acetyltransferase enzyme and developed hydrogen bond and two arene-cation and arene-arene interactions with active site residue Arg176, Arg124 and Trp180. histone acetyltransferase